Chao Hong Hu
Nessuna posizione attualmente
Patrimonio netto: 90 M $ in data 31/05/2024
Storia della carriera di Chao Hong Hu
Precedenti posizioni note di Chao Hong Hu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Direttore/Membro del Consiglio | 16/05/2020 | 31/01/2024 |
| Amministratore Delegato | 16/05/2020 | 31/01/2024 | |
| SEAGEN INC. | Corporate Officer/Principal | 01/06/2007 | 01/10/2013 |
| GSK PLC | Corporate Officer/Principal | 01/01/2006 | 01/05/2007 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | 01/01/2005 |
Shanghai Miracogen, Inc.
 Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Amministratore Delegato | 01/01/2014 | - |
| Presidente | 01/01/2014 | - | |
| Fondatore | 01/01/2014 | - |
Formazione di Chao Hong Hu
| Wuhan University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 4 |
| Stati Uniti | 2 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Chao Hong Hu
- Esperienza
